Nodality, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nodality, Inc.
Execs On The Move, September 2015
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medtech Execs On The Move, September 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
With Latest RA Deal, Janssen Seeks To Improve Outcomes With Small Molecules
Janssen gets option to Modern’s small-molecule candidates for rheumatoid arthritis that could address both the inflammatory and bone-damaging effects of the disease. An R&D exec says the compounds could be complementary to, or used in combination with, Remicade and Simponi, or as standalone RA therapies.
Medtech Execs On The Move, September 2014
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Company Information
- Industry
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Drug Discovery Tools
- Pharmacogenetics-Pharmacogenomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice